Leaders from India’s top drug makers discuss efforts to operationalize a world-class skilling institute, backed by tie-ups with organizations like the PDA, ISPE and also taking a leaf out of the automobile industry’s book to build supply chain resilience. They also exuded confidence on moving up the innovation value chain.
US Food and Drug Administration (FDA) Commissioner Robert Califf appears to have contributed to nudging a pivotal effort to build biopharma’s talent pool in India and fostering a culture of manufacturing and quality excellence.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
